Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
2,226.70
+21.90 (0.99%)
Jul 17, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 14,989 employees as of March 31, 2024. The number of employees decreased by 567 or -3.64% compared to the previous year.
Employees
14,989
Change (1Y)
-567
Growth (1Y)
-3.64%
Revenue / Employee
8.96M INR
Profits / Employee
698.58K INR
Market Cap
628.38B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 30,313 |
Mankind Pharma | 19,540 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Fortis Healthcare | 12,088 |
Glenmark Pharmaceuticals News
- 3 days ago - Top stocks to buy: Stock recommendations for the week starting July 14, 2025 - check list - The Times of India
- 3 days ago - Top stocks in focus on July 14; DMart, Glenmark Pharma, VIP Industries, NCC, RITES, Ajmera Realty and more - Business Upturn
- 3 days ago - HSBC raises Glenmark Pharma share price target to Rs 2,275 on $1.9 billion AbbVie licensing deal - Business Upturn
- 5 days ago - Glenmark Pharma receives warning letter from US FDA for Indore facility - Business Upturn
- 6 days ago - Glenmark Pharma shares surge 10% after its subsidiary signs $700 million licensing deal with AbbVie for ISB 2001 - Business Upturn
- 6 days ago - Top stocks in focus on July 11: Tata Steel, TCS, Tata Elxsi, Glenmark Pharma, HUL, JSW Infrastructure and more - Business Upturn
- 6 days ago - Glenmark shares in focus after $700 million AbbVie deal for ISB 2001 - Business Upturn
- 7 days ago - Glenmark Pharma’s subsidiary IGI Therapeutics signs $700 million licensing deal with AbbVie for ISB 2001 - Business Upturn